Related Stories
Photos
Quotations
"Since its establishment, Uni-pharma has been active in research, development, manufacturing and marketing of pharmaceuticals of the highest quality, covering all major therapeutic areas, with innovative, ground-breaking products of their time, such as IV paracetamol, APOTEL and enteric-coated low-dose ASA, SALOSPIR, as well as technologically challenging products such as Levothyroxine Sodium, T4" explained Mrs. Julia Tseti, CEO of The Tsetis Pharmaceutical Group of Companies (OFET).
International collaborations and sustainability on top of Tseti's agenda →
